Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma

Name: Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma
Published: 2017
License: Public Domain

Brown University · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

cell lymphoma small

lymphoma, non-hodgkin, lymphoma, follicular, lymphoma, mantle-cell, lymphoma, small-cell, waldenstrom macroglobulinemia, lymphoma, b-cell, marginal zone, bendamustine, rituximab, vincristine sulfate, vincristine sulfate liposome injection, phase i, escalation with overdose control

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 881871
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.